We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2013 by Shenzhen Ausa Pharmed Co.,Ltd.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01848873
First Posted: May 8, 2013
Last Update Posted: May 8, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Peking University First Hospital
Chinese PLA General Hospital
Capital Medical University
Fudan University
Ruijin Hospital
Nanchang University
First Affiliated Hospital of Fujian Medical University
First Affiliated Hospital of Harbin Medical University
China Medical University, China
Health Science Center of Xi’an Jiaotong University
Xuzhou Medical University
Anhui Medical University
Huazhong University of Science and Technology
West China Hospital
Guangdong General Hospital
Second Affiliated Hospital, School of Medicine, Zhejiang University
Information provided by (Responsible Party):
Shenzhen Ausa Pharmed Co.,Ltd
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2013
  Estimated Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)